Ray Moynihan. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisFinancing, GovernmentHumansPharmaceutical Preparations/economicsUnited States
Substances: See more » Pharmaceutical Preparations
Year: 2003 PMID: 14500428 PMCID: PMC196387 DOI: 10.1136/bmj.327.7416.642
Source DB: PubMed Journal: BMJ ISSN: 0959-8138